30 years of historical data (1996–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Assertio Holdings, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $144M | $58M | $6M | $5M | $16M | $6M | $3M | $6M | $15M | $34M | $74M |
| Enterprise Value | $173M | $87M | $-4789295 | $-28698122 | $18M | $45M | $71M | $322M | $471M | $532M | $615M |
| P/E Ratio → | -4.72 | — | — | — | 0.14 | — | — | — | 0.42 | — | — |
| P/S Ratio | 1.21 | 0.49 | 0.04 | 0.03 | 0.10 | 0.06 | 0.02 | 0.03 | 0.05 | 0.09 | 0.16 |
| P/B Ratio | 1.52 | 0.62 | 0.05 | 0.04 | 0.07 | 0.06 | 0.05 | 0.10 | 0.07 | 0.20 | 0.29 |
| P/FCF | — | — | 0.21 | 0.10 | 0.20 | 1.15 | — | 0.07 | 0.23 | 0.55 | 1.18 |
| P/OCF | — | — | 0.21 | 0.10 | 0.20 | 1.14 | — | 0.07 | 0.21 | 0.54 | 1.12 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Assertio Holdings, Inc.'s enterprise value stands at 20.4x EBITDA, 423% above its 5-year average of 3.9x. The Healthcare sector median is 14.4x, placing the stock at a 42% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.73 | -0.04 | -0.19 | 0.11 | 0.41 | 0.66 | 1.40 | 1.51 | 1.40 | 1.35 |
| EV / EBITDA | 20.37 | 10.27 | -3.54 | — | 0.24 | 1.18 | — | — | 3.14 | 8.41 | 4.59 |
| EV / EBIT | — | — | — | -1.15 | 0.31 | 4.69 | — | — | 4.40 | — | 32.00 |
| EV / FCF | — | — | -0.18 | -0.59 | 0.22 | 8.29 | — | 3.62 | 7.03 | 8.65 | 9.82 |
Margins and return-on-capital ratios measuring operating efficiency
Assertio Holdings, Inc. earns an operating margin of -18.1%. Operating margins have expanded from -160.1% to -18.1% over the past 3 years, signaling improving operational efficiency. A negative ROE of -27.4% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.2% | 70.2% | 68.6% | 82.2% | 88.0% | 85.7% | 85.4% | 95.9% | 94.1% | 80.9% | 80.8% |
| Operating Margin | -18.1% | -18.1% | -19.6% | -160.1% | 25.2% | 8.5% | -76.0% | -84.7% | 14.0% | -11.1% | 5.4% |
| Net Profit Margin | -24.9% | -24.9% | -17.3% | -218.3% | 70.2% | -1.2% | -26.0% | -94.6% | 11.8% | -26.9% | -19.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -27.4% | -27.4% | -16.7% | -182.5% | 66.8% | -1.6% | -49.6% | -156.1% | 18.9% | -48.8% | -31.4% |
| ROA | -10.7% | -10.7% | -7.6% | -94.8% | 29.6% | -0.4% | -6.8% | -29.8% | 3.7% | -9.1% | -6.9% |
| ROIC | -13.8% | -13.8% | -17.1% | -110.1% | 16.0% | 5.3% | -24.7% | -27.8% | 4.9% | -4.3% | 2.2% |
| ROCE | -13.9% | -13.9% | -13.5% | -95.2% | 15.4% | 5.2% | -32.0% | -33.8% | 5.4% | -4.6% | 2.3% |
Solvency and debt-coverage ratios — lower is generally safer
Assertio Holdings, Inc. carries a Debt/EBITDA ratio of 4.6x, which is highly leveraged (40% above the sector average of 3.3x). Net debt stands at $29M ($39M total debt minus $10M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.42 | 0.42 | 0.33 | 0.29 | 0.30 | 0.74 | 1.61 | 6.18 | 2.57 | 3.70 | 2.87 |
| Debt / EBITDA | 4.62 | 4.62 | 29.76 | — | 0.92 | 1.97 | — | — | 3.77 | 9.90 | 5.37 |
| Net Debt / Equity | — | 0.31 | -0.09 | -0.24 | 0.01 | 0.38 | 1.24 | 5.45 | 2.07 | 2.94 | 2.16 |
| Net Debt / EBITDA | 3.41 | 3.41 | -7.63 | — | 0.03 | 1.01 | — | — | 3.03 | 7.87 | 4.04 |
| Debt / FCF | — | — | -0.39 | -0.69 | 0.02 | 7.14 | — | 3.55 | 6.79 | 8.11 | 8.64 |
| Interest Coverage | -7.00 | -7.00 | -8.05 | -72.05 | 4.95 | 0.92 | -5.16 | -3.33 | 0.63 | -0.57 | 0.29 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.70x means Assertio Holdings, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.83x to 1.70x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.70 | 1.70 | 1.77 | 1.83 | 1.39 | 0.77 | 0.71 | 0.56 | 1.73 | 1.03 | 1.39 |
| Quick Ratio | 1.51 | 1.51 | 1.43 | 1.43 | 1.24 | 0.71 | 0.62 | 0.54 | 1.70 | 0.97 | 1.33 |
| Cash Ratio | 0.50 | 0.50 | 0.87 | 0.79 | 0.68 | 0.27 | 0.16 | 0.23 | 0.89 | 0.57 | 0.80 |
| Asset Turnover | — | 0.44 | 0.44 | 0.53 | 0.38 | 0.34 | 0.36 | 0.44 | 0.33 | 0.37 | 0.37 |
| Inventory Turnover | 1.47 | 1.47 | 1.02 | 0.72 | 1.37 | 2.11 | 1.35 | 2.79 | 5.44 | 5.57 | 6.71 |
| Days Sales Outstanding | — | 369.30 | 158.08 | 114.40 | 105.96 | 143.85 | 149.78 | 67.97 | 43.56 | 69.49 | 82.13 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Assertio Holdings, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 708.1% | — | — | — | 238.9% | — | — |
| FCF Yield | — | — | 477.3% | 966.6% | 499.8% | 87.2% | — | 1510.2% | 433.5% | 182.8% | 85.1% |
| Buyback Yield | 0.0% | 0.0% | 6.3% | 100.0% | 5.3% | 6.7% | 34.4% | 9.7% | 4.4% | 2.2% | 4.5% |
| Total Shareholder Yield | 0.0% | 0.0% | 6.3% | 100.0% | 5.3% | 6.7% | 34.4% | 9.7% | 4.4% | 2.2% | 4.5% |
| Shares Outstanding | — | $6M | $6M | $5M | $4M | $3M | $2M | $1M | $1M | $1M | $1M |
Compare ASRT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $144M | -4.7 | 20.4 | — | 70.2% | -18.1% | -27.4% | -13.8% | 4.6 | |
| $2B | 36.3 | 15.7 | 41.8 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 | |
| $4B | 62.4 | — | 16.0 | 36.9% | -0.2% | 15.7% | -0.2% | — | |
| $3B | -76.9 | 53.4 | 65.5 | 89.6% | -5.1% | -3.7% | -2.8% | 0.7 | |
| $2B | -1.1 | 7.4 | 11.1 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 | |
| $1B | 22.7 | 4.8 | 3.9 | 59.3% | 24.0% | 23.7% | 14.0% | 2.3 | |
| $2B | 11.6 | 5.6 | 5.2 | 77.2% | 24.0% | 20.8% | 42.0% | 1.0 | |
| $2B | -42.4 | — | — | 91.0% | -25.1% | -60.4% | -76.3% | — | |
| $2B | 13.3 | 6.4 | 2.1 | 60.9% | 21.3% | 588.2% | 8.2% | 6.1 | |
| $42B | 30.0 | 17.6 | 36.5 | 51.8% | 12.5% | 20.7% | 7.7% | 5.5 | |
| $930M | 147.8 | 9.9 | 6.8 | 79.4% | 4.6% | 1.0% | 2.3% | 3.7 | |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Phibro Animal Health Corporation.
Start ComparisonQuick answers to the most common questions about buying ASRT stock.
Assertio Holdings, Inc.'s current P/E ratio is -4.7x. The historical average is 1.2x.
Assertio Holdings, Inc.'s current EV/EBITDA is 20.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.1x.
Assertio Holdings, Inc.'s return on equity (ROE) is -27.4%. The historical average is -59.4%.
Based on historical data, Assertio Holdings, Inc. is trading at a P/E of -4.7x. Compare with industry peers and growth rates for a complete picture.
Assertio Holdings, Inc. has 70.2% gross margin and -18.1% operating margin.
Assertio Holdings, Inc.'s Debt/EBITDA ratio is 4.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.